Literature DB >> 6255902

Infection of rhesus monkeys and chimpanzees with Epstein-Barr virus.

P H Levine, S A Leiseca, J F Hewetson, K A Traul, A P Andrese, D J Granlund, P Fabrizio, D A Stevens.   

Abstract

Seventy-two nonhuman primates were entered into a long-term study to evaluate the pathogenicity of Epstein-Barr virus (EBV). Infectious virus was inoculated into 42 rhesus monkeys, 4 chimpanzees and 1 cynomolgus monkey. Immunostimulation or immunosuppression was attempted in 34 of these animals to enhance the oncogenic potential of the virus. Eleven inoculated animals were followed for more than 3 years and two were observed for 8 years. No tumors were observed in any of the animals; however, serological evaluation of the 47 inoculated primates and 25 matched controls indicated that at least 14 rhesus monkeys and the cynomolgus monkey were successfully infected with EBV. The potential use of rhesus monkeys as a model for EBV-induced disease in humans is discussed.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6255902     DOI: 10.1007/bf01320630

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  35 in total

1.  Immortalizing and nonimmortalizing laboratory strains of Epstein-Barr Virus.

Authors:  G Miller; J Robinson; L Heston
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1975

2.  Antibodies to Epstein-Barr virus (EBV) in American patients with Burkitt's lymphoma.

Authors:  P H Levine; G T O'Conor; C W Bernard
Journal:  Cancer       Date:  1972-09       Impact factor: 6.860

3.  Elevated antibody titers to Epstein-Barr virus in Hodgkin's disease.

Authors:  P H Levine; D V Ablashi; C W Berard; P P Carbone; D E Waggoner; L Malan
Journal:  Cancer       Date:  1971-02       Impact factor: 6.860

4.  Sarcoidosis, another disease associated with serologic evidence for herpes-like virus infection.

Authors:  Y Hirshaut; P Glade; B D Vieira; E Ainbender; B Dvorak; L E Siltzbach
Journal:  N Engl J Med       Date:  1970-09-03       Impact factor: 91.245

5.  Immunofluorescence in cells derived from Burkitt's lymphoma.

Authors:  G Henle; W Henle
Journal:  J Bacteriol       Date:  1966-03       Impact factor: 3.490

6.  Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines.

Authors:  B M Reedman; G Klein
Journal:  Int J Cancer       Date:  1973-05       Impact factor: 7.396

7.  Response of marmosets to experimental infection with Epstein-Barr virus.

Authors:  F Deinhardt; L Falk; L G Wolfe; J Paciga; D Johnson
Journal:  IARC Sci Publ       Date:  1975

8.  Probable identification of an HL-A second-locus antigen associated with a high risk of nasopharyngeal carcinoma.

Authors:  M J Simons; G B Wee; S H Chan; K Shanmugaratnam
Journal:  Lancet       Date:  1975-01-18       Impact factor: 79.321

9.  Antigens and DNA of a chimpanzee agent related to Epstein-Barr virus.

Authors:  P Gerber; R F Pritchett; E D Kieff
Journal:  J Virol       Date:  1976-09       Impact factor: 5.103

10.  Differential reactivity of human serums with early antigens induced by Epstein-Barr virus.

Authors:  W Henle; G Henle; B A Zajac; G Pearson; R Waubke; M Scriba
Journal:  Science       Date:  1970-07-10       Impact factor: 47.728

View more
  10 in total

Review 1.  Simian homologues of Epstein-Barr virus.

Authors:  F Wang; P Rivailler; P Rao; Y Cho
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-04-29       Impact factor: 6.237

Review 2.  Simian herpesviruses and their risk to humans.

Authors:  Ryan D Estep; Ilhem Messaoudi; Scott W Wong
Journal:  Vaccine       Date:  2010-05-26       Impact factor: 3.641

3.  Infection of human B lymphocytes with lymphocryptoviruses related to Epstein-Barr virus.

Authors:  A Moghaddam; J Koch; B Annis; F Wang
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

4.  Mechanisms that regulate Epstein-Barr virus EBNA-1 gene transcription during restricted latency are conserved among lymphocryptoviruses of Old World primates.

Authors:  I K Ruf; A Moghaddam; F Wang; J Sample
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

5.  Potential role of human-specific genes, human-specific microRNAs and human-specific non-coding regulatory RNAs in the pathogenesis of systemic sclerosis and Sjögren's syndrome.

Authors:  Sergio A Jimenez; Sonsoles Piera-Velazquez
Journal:  Autoimmun Rev       Date:  2013-05-15       Impact factor: 9.754

6.  Simian TRIM5alpha proteins reduce replication of herpes simplex virus.

Authors:  Natalia Reszka; Changhong Zhou; Byeongwoon Song; Joseph G Sodroski; David M Knipe
Journal:  Virology       Date:  2010-01-12       Impact factor: 3.616

7.  5' Coding and regulatory region sequence divergence with conserved function of the Epstein-Barr virus LMP2A homolog in herpesvirus papio.

Authors:  M Franken; B Annis; A N Ali; F Wang
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

8.  Epstein-Barr Virus gp350 Can Functionally Replace the Rhesus Lymphocryptovirus Major Membrane Glycoprotein and Does Not Restrict Infection of Rhesus Macaques.

Authors:  Marissa Herrman; Janine Mühe; Carol Quink; Fred Wang
Journal:  J Virol       Date:  2015-11-11       Impact factor: 5.103

9.  Mountain gorilla lymphocryptovirus has Epstein-Barr virus-like epidemiology and pathology in infants.

Authors:  Tierra Smiley Evans; Linda J Lowenstine; Kirsten V Gilardi; Peter A Barry; Benard J Ssebide; Jean Felix Kinani; Fred Nizeyimana; Jean Bosco Noheri; Michael R Cranfield; Antoine Mudakikwa; Tracey Goldstein; Jonna A K Mazet; Christine Kreuder Johnson
Journal:  Sci Rep       Date:  2017-07-13       Impact factor: 4.379

Review 10.  Macaque models of human infectious disease.

Authors:  Murray B Gardner; Paul A Luciw
Journal:  ILAR J       Date:  2008
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.